Cambio Healthcare Systems AB (publ) enters into a formal exclusive process to acquire Operative business of FRISQ Holding AB from FRISQ Holding AB (publ) (OM:FRISQ) for SEK 40 million on July 21, 2022. The proposal is to enter into an exclusive process to finalize the necessary due diligence required by Cambio, with the objective to reach a final and binding offer to acquire the operational business of FRISQ in the beginning of September. FRISQ will then call an EGM to secure the shareholders vote that is required to finalize a potential transaction. The target is to achieve closing of the deal no later than the end of September. During the exclusivity period, Cambio will extend a loan of maximum SEK 6 million to FRISQ and FRISQ will discontinue discussions with other potential acquirers during the period. FRISQ, the Board has decided to accept a proposal from Cambio. The Board of FRISQ Holding AB ("FRISQ") has received a binding, conditional offer from Cambio Healthcare Systems AB ("Cambio") of SEK 40 million for acquiring FRISQ's operational business. The Board will call an extraordinary general meeting on October 31 and recommends to the shareholders that the offer should be accepted. The Board intends to replace FRISQ AB with an acquisition of a new business during Q4 2022. A separate general meeting for this acquisition will be convened before the end of the current year.As previously announced, the Board of FRISQ has, after several months of evaluation, found that Cambio is the best long-term owner of the business. After an exclusive negotiation period, Cambio has presented a binding, conditional offer of SEK 40 million divided into a purchase price of SEK 31 million upon entry and an additional purchase price of SEK 9 million within a 6-month period.
The offer is binding until October 31, 2022. In order for the deal to be completed, approval is required at the extraordinary general meeting on October 31 and binding share transfer agreements must be concluded between the parties by October 31 at the latest.